Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

January 01, 2022; Volume 101,Issue 1

Minireview

  • You have access
    Mechanisms to Repair Stalled Topoisomerase II-DNA Covalent Complexes
    Rebecca L. Swan, Ian G. Cowell and Caroline A. Austin
    Molecular Pharmacology January 2022, 101 (1) 24-32; DOI: https://doi.org/10.1124/molpharm.121.000374

Articles

  • You have access
    Ibrutinib Blocks YAP1 Activation and Reverses BRAF Inhibitor Resistance in Melanoma Cells
    Sean A. Misek, Patrick A. Newbury, Evgenii Chekalin, Shreya Paithankar, Andrea I. Doseff, Bin Chen, Kathleen A. Gallo and Richard R. Neubig
    Molecular Pharmacology January 2022, 101 (1) 1-12; DOI: https://doi.org/10.1124/molpharm.121.000331
  • You have access
    Chrysosplenol-C Increases Contraction by Augmentation of Sarcoplasmic Reticulum Ca2+ Loading and Release via Protein Kinase C in Rat Ventricular Myocytes
    J. Wang, T.N. Trinh, A. T. V. Vu, J.C. Kim, A.T.N. Hoang, C.J. Ohk, Y.H. Zhang, C.M. Nguyen and S.H. Woo
    Molecular Pharmacology January 2022, 101 (1) 13-23; DOI: https://doi.org/10.1124/molpharm.121.000365
  • You have access
    Structural Basis of the Negative Allosteric Modulation of 5-BDBD at Human P2X4 Receptors
    Stefan Bidula, Izzuddin Bin Nadzirin, Marco Cominetti, Harry Hickey, Sean A. Cullum, Mark Searcey, Ralf Schmid and Samuel J. Fountain
    Molecular Pharmacology January 2022, 101 (1) 33-44; DOI: https://doi.org/10.1124/molpharm.121.000402
  • You have access
    Decoding Cinnabarinic Acid–Specific Stanniocalcin 2 Induction by Aryl Hydrocarbon Receptor
    Nikhil Y. Patil, Hui Tang, Iulia Rus, Kangling Zhang and Aditya D. Joshi
    Molecular Pharmacology January 2022, 101 (1) 45-55; DOI: https://doi.org/10.1124/molpharm.121.000376
  • Steroidal Antagonists of Progesterone- and Prostaglandin E<sub>1</sub>-Induced Activation of the Cation Channel of Sperm
    Open Access
    Steroidal Antagonists of Progesterone- and Prostaglandin E1-Induced Activation of the Cation Channel of Sperm
    Erick J. Carlson, Gunda I. Georg and Jon E. Hawkinson
    Molecular Pharmacology January 2022, 101 (1) 56-67; DOI: https://doi.org/10.1124/molpharm.121.000349
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 101 (1)
Molecular Pharmacology
Vol. 101, Issue 1
1 Jan 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Minireview
  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics